View by Specialty

Headline News

View more

FDA panel backs residual disease as ‘reasonable surrogate’ endpoint in myeloma trials

April 16, 2024
2 min read
Save

FDA panel backs residual disease as ‘reasonable surrogate’ endpoint in myeloma trials

FDA panel backs residual disease as ‘reasonable surrogate’ endpoint in myeloma trials

An FDA advisory committee unanimously voted minimal residual disease should be an accepted endpoint for accelerated approval of clinical trials investigating treatments for patients with multiple myeloma.

View more Headline News
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails

Resources

View more

AI in Medicine

23007715_AIinMedicineRC_OG

Artificial intelligence is a rapidly evolving field. Learn how and why it is being applied in clinical practice in multiple medical specialties.

View resource

AAO Perspectives

24009397_AAOResourceCenter_OG

American Academy of Optometry members provide perspective on recent research through the Eye-Mail News Brief. Brought to you by the AAO Communications Committee.

View resource
View more Resources
View more Meeting News

Podcasts

View more
Ophthalmology Eyeluminaries OG
April 11, 2024
32 min listen

Live from Eyecelerator at ASCRS 2024

Practice Management, Retina/Vitreous 22005361_Healio Minute_OG_1200x630
Hematology/Oncology Oncology Overdrive
April 04, 2024
32 min listen

Global GI Oncology with Aparna Parikh, MD

View more Podcasts

Blogs & Columns

View more
John Hovanesian 2019

Blog by John A. Hovanesian, MD, FACS

with John A. Hovanesian, MD, FACS
John A. Hovanesian, MD, FACS, focuses his blog on new technologies and innovations and how ophthalmic practices can best incorporate them to benefit patients.
Oliver Kuhn-Wilken, OD

Comanagement Conundrums

with Oliver Kuhn-Wilken, OD
Oliver Kuhn-Wilken, OD, of Pacific Cataract and Laser Institute, discusses comanagement of cataract, refractive, glaucoma and corneal surgery, including concepts and postoperative complications.

View more Blogs & Columns